These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 7769052

  • 1. Substrate dependency of C19 conjugates in hirsute hyperandrogenic women and the influence of adrenal androgen.
    Carmina E, Gentzschein E, Stanczyk FZ, Lobo RA.
    Hum Reprod; 1995 Feb; 10(2):299-303. PubMed ID: 7769052
    [Abstract] [Full Text] [Related]

  • 2. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
    Stanczyk FZ, Saxena T, Lobo RA.
    J Steroid Biochem Mol Biol; 2014 Jan; 139():73-7. PubMed ID: 24121067
    [Abstract] [Full Text] [Related]

  • 3. Androgen sulfate and glucuronide conjugates in nonhirsute and hirsute women with polycystic ovarian syndrome.
    Matteri RK, Stanczyk FZ, Gentzschein EE, Delgado C, Lobo RA.
    Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 1):1704-9. PubMed ID: 2532471
    [Abstract] [Full Text] [Related]

  • 4. Androsterone sulfate: physiology and clinical significance in hirsute women.
    Zwicker H, Rittmaster RS.
    J Clin Endocrinol Metab; 1993 Jan; 76(1):112-6. PubMed ID: 8380602
    [Abstract] [Full Text] [Related]

  • 5. Serum androsterone conjugates differentiate between acne and hirsutism in hyperandrogenic women.
    Carmina E, Stanczyk FZ, Matteri RK, Lobo RA.
    Fertil Steril; 1991 May; 55(5):872-6. PubMed ID: 1827073
    [Abstract] [Full Text] [Related]

  • 6. Increased free testosterone but normal 5 alpha-reduced testosterone metabolites in obese premenopausal women.
    Giagulli VA, De Pergola G, Giorgino F, Cignarelli M, Abbaticchio G, Vermeulen A, Giorgino R.
    Clin Endocrinol (Oxf); 1992 Jun; 36(6):553-8. PubMed ID: 1424180
    [Abstract] [Full Text] [Related]

  • 7. Assessment of 5 alpha-reductase activity in hirsute women: comparison of serum androstanediol glucuronide with urinary androsterone and aetiocholanolone excretion.
    Gilad S, Chayen R, Tordjman K, Kisch E, Stern N.
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):459-64. PubMed ID: 8187312
    [Abstract] [Full Text] [Related]

  • 8. The ovarian contribution to peripherally derived serum C19 conjugates.
    Matteri RK, Stanczyk FZ, Cassidenti DL, Paulson RJ, Lobo RA.
    J Clin Endocrinol Metab; 1992 Sep; 75(3):768-72. PubMed ID: 1387653
    [Abstract] [Full Text] [Related]

  • 9. Androsterone glucuronide is a marker of adrenal hyperandrogenism in hirsute women.
    Thompson DL, Horton N, Rittmaster RS.
    Clin Endocrinol (Oxf); 1990 Mar; 32(3):283-92. PubMed ID: 2160872
    [Abstract] [Full Text] [Related]

  • 10. Normal and elevated 3 alpha-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels.
    Pang S, Wang M, Jeffries S, Riddick L, Clark A, Estrada E.
    J Clin Endocrinol Metab; 1992 Jul; 75(1):243-8. PubMed ID: 1535633
    [Abstract] [Full Text] [Related]

  • 11. Plasma levels of C19 steroid glucuronides in pre-menopausal women with non-classical congenital adrenal hyperplasia.
    Whorwood CB, Ueshiba H, del Blazo P.
    J Steroid Biochem Mol Biol; 1992 Apr; 42(2):211-21. PubMed ID: 1314640
    [Abstract] [Full Text] [Related]

  • 12. Time-dependent changes in serum 3 alpha-androstanediol glucuronide correlate with hirsutism scores after ovarian suppression.
    Carmina E, Stanczyk FZ, Gentzchein E, Lobo RA.
    Gynecol Endocrinol; 1995 Sep; 9(3):215-20. PubMed ID: 8540291
    [Abstract] [Full Text] [Related]

  • 13. Cutaneous application of an androstenedione gel as an in vivo test of 5 alpha-reductase activity in women.
    Miles RA, Cassidenti DL, Carmina E, Gentzschein E, Stanczyk FZ, Lobo RA.
    Fertil Steril; 1992 Oct; 58(4):708-12. PubMed ID: 1426314
    [Abstract] [Full Text] [Related]

  • 14. Alterations in androgen conjugate levels in women and men with alopecia.
    Legro RS, Carmina E, Stanczyk FZ, Gentzschein E, Lobo RA.
    Fertil Steril; 1994 Oct; 62(4):744-50. PubMed ID: 7926083
    [Abstract] [Full Text] [Related]

  • 15. Plasma levels of C-19 steroids and 5 alpha-reduced steroid glucuronides in hyperandrogenic and idiopathic hirsute women.
    Brochu M, Bélanger A, Tremblay RR.
    Fertil Steril; 1987 Dec; 48(6):948-53. PubMed ID: 2960564
    [Abstract] [Full Text] [Related]

  • 16. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS, Thompson DL.
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [Abstract] [Full Text] [Related]

  • 17. Plasma 5 alpha-reduced androgens in men and hirsute women: role of adrenals and gonads.
    Meikle AW, Stringham JD, Wilson DE, Dolman LI.
    J Clin Endocrinol Metab; 1979 Jun; 48(6):969-75. PubMed ID: 447804
    [No Abstract] [Full Text] [Related]

  • 18. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
    Carmina E, Lobo RA.
    Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
    [Abstract] [Full Text] [Related]

  • 19. Two different pathogenetic mechanisms may play a role in acne and in hirsutism.
    Toscano V, Balducci R, Bianchi P, Guglielmi R, Mangiantini A, Rossi FG, Colonna LM, Sciarra F.
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):551-6. PubMed ID: 8252744
    [Abstract] [Full Text] [Related]

  • 20. Serum androstanediol glucuronide in women with facial hirsutism.
    Salman K, Spielvogel RL, Shulman LH, Miller JL, Vanderlinde RE, Rose LI.
    J Am Acad Dermatol; 1992 Mar; 26(3 Pt 2):411-4. PubMed ID: 1564146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.